51 postdoc-in-distributed-systems-and-controls-"Multiple" PhD positions at University of East Anglia
Sort by
Refine Your Search
-
Primary supervisor - Dr Edwin Ren Autonomous Aerial Systems (AASs), commonly known as drones or UAV, are rapidly advancing in capability, enabling them to perform a wide range of urban tasks such as
-
plants. To better understand how distantly-related land plants defend themselves against pathogen infection, our group investigates the molecular genetic mechanisms controlling disease resistance in
-
Primary Supervisor - Dr Lidong Be Scientific Background One of the key challenges in volcanology is understanding changes in volcanic activities during crises, such as transitions from effusive
-
modifications affect topoisomerase activity during C. elegans nervous system development. This multidisciplinary project provides advanced training in molecular genetics, genomics, and translational biotechnology
-
confined battery geometries. Advanced modelling—including computational fluid dynamics (CFD) and transient thermal analysis—is required to accurately capture heat flux distributions, temperature uniformity
-
the field operations of addition and multiplication, raising to a fixed power is the most basic and universal operation in mathematics. However, the model theory of the complex field with fixed (irrational
-
Project Supervisor - Dr YingLiang Ma Background Cardiovascular disease is the leading cause of death in the UK. As of 2023, over 1.6 million people in the UK have been diagnosed with heart
-
secondary supervisor Dr Falk Hildebrand (Quadram Institute), who is an expert in bacterial metagenomics associated with diseases such as IBD and has developed multiple tools for understanding complex
-
subtype stx2a is linked to a higher chance of this progression and sequence-based surveillance has indicated increasing acquisition of this subtype across genetically diverse E. coli. In this project, we
-
Each year, approximately 6,000 people in the UK are diagnosed with multiple myeloma. Despite advances in therapy, infections remain a leading cause of morbidity and early mortality in these patients